Children’s Mercy, SN Genelab, and Xcelom join Genetic Alliance’s global laboratory network Every laboratory we add to ...

A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic condition. Leo Freiberg, from Seaford, has PGAP3-CDG, a genetic metabolic ...

The company, which currently generates around ₹700 crore in annual revenues, has been growing at about 35% a year, says Vedam ...

Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug discovery and clinical ...

A lot of effort has gone into finding ways to minimize or eliminate off-target edits. In a recent issue of Nature, ...

A recent Northwestern Medicine study offers new data on previously unknown genetic variants that cause tuberous sclerosis ...

The dangers of antibiotic overuse have become increasingly clear in recent decades. Excessive use accelerates the evolution of bacterial resistance to antibiotics, raising the alarming prospect of ...

The molecular machinery that normally builds proteins inside cells has now taken on a new role as a "switch." A research team at POSTECH (Pohang University of Science and Technology) has developed a ...